7:30 a.m.
|
Continental Breakfast / Exhibits
|
Session XIII:
Emerging Role of Novel Anti-seizure Medications and Genetics in Epilepsy Management
|
8:00 a.m.
|
Current State of Knowledge in Epilepsy
|
8:20 a.m.
|
Epigenetics in Epilepsy
|
8:40 a.m.
|
Single Gene Methylation
|
9:00 a.m.
|
Towards a More Personalized Treatment with Anti-seizure Medications
|
9:20 a.m.
|
Are We Ready for Gene-based Therapies? Future Perspectives
|
9:40 a.m.
|
Panel Discussion of New Anti-Seizure Medications and Gene Therapy
|
10:00 a.m.
|
Break / Exhibits
|
Session XIV:
Signal Processing, Engineering and AI: Trends in Epilepsy
|
10:20 a.m.
|
Non-Invasice Mapping of Connectivity in Epileptic Network
|
10:40 a.m.
|
Normative Brain Mapping: Scalp EEG, MEG, and Intracranial EEG
|
11:00 a.m.
|
4-Dimensional Mapping of Epileptic Networks
|
11:20 a.m.
|
AI in Detection and Analysis of intracranial EEG
|
11:40 a.m.
|
Taxonomy of Seizure Dynamotypes and Modeling of Epilepstic Seizures
|
12:00 p.m.
|
Epileptiform Dynamics in SEEG: Neuroengineering, AI and the Renaissance in Epilepsy Surgery
|
12:20 p.m.
|
Lunch / Adjourn
|